|
|
Volumn 29, Issue 5, 1997, Pages 2356-2357
|
|
Intrathecal allograft of chromaffin cells for intractable pain treatment: A model for understanding CNS tolerance mechanisms in humans
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CD4 ANTIGEN;
CD8 ANTIGEN;
CYCLOSPORIN;
CYTOKINE;
GAMMA INTERFERON;
HLA ANTIGEN CLASS 2;
INTERLEUKIN 10;
INTERLEUKIN 2;
INTERLEUKIN 6;
MORPHINE;
TRANSFORMING GROWTH FACTOR BETA1;
ALLOGRAFT;
ANALGESIA;
CANCER PAIN;
CENTRAL NERVOUS SYSTEM;
CHROMAFFIN CELL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
HUMAN;
IMMUNOLOGICAL TOLERANCE;
INTRACTABLE PAIN;
INTRATHECAL DRUG ADMINISTRATION;
LYMPHOCYTIC INFILTRATION;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
ANIMALS;
BRAIN;
BRAIN NEOPLASMS;
CHROMAFFIN CELLS;
GRAFT SURVIVAL;
HUMANS;
PAIN, INTRACTABLE;
RATS;
TRANSPLANTATION, HOMOLOGOUS;
|
|
EID: 0030779071
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(97)00401-6 Document Type: Conference Paper |
|
Times cited : (6)
|
|
References (14)
|
